Menu
Recruiting NCT06287177

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

— Observational Hypercholesterolemia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Inclisiran.
Who it may be relevant to
Registry conditions: Hypercholesterolemia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - CHOLINET (CHOLesterol Italian Inclisiran NETwork)

Overview

Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population

Interventions

  • Drug Inclisiran
    Injection

Primary outcome measures

  • Description of adherence to treatment with Inclisiran in a real-life Italian population [Time frame: at 3 months and every 6 months thereafter]
  • Description of persistence to treatment with Inclisiran in a real-life Italian population [Time frame: at 3 months and every 6 months thereafter]
  • Description of efficacy of treatment with Inclisiran in a real-life Italian population [Time frame: at 3 months and every 6 months thereafter]

Eligibility criteria

Inclusion criteria

  • Patients under Inclisiran treatment

Exclusion criteria

  • Age < 18 years o > 80 years
  • Patients who refuse to participate and to sign informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Italy · 1 center
  • Federico II University of Naples, Department of Advanced Biomedical Sciences — Naples

Identifiers

NCT: NCT06287177 · Protocol 28/2023

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗